Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2019-03-14
2019-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the United Kingdom (UK) there is no up to date QALY data for women with early breast cancer treated with surgery followed by radiotherapy. The OSTaRa Study aims to provide up to date QALY data for women in this cohort.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breast Cancer and Quality of Life
NCT01661816
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776
Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients
NCT05064098
Healthy Lifestyles and Quality of Life in Women With Breast Cancer
NCT04379908
5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma
NCT02791750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Disease free
Women who have been treated for early breast cancer with breast conserving surgery and radiotherapy and at the time of completing study questionnaires are disease free.
EQ5D questionnaire and a demographic questionnaire
questionnaires
Local recurrences
Women who have been treated for early breast cancer with breast conserving surgery and radiotherapy and at the time of completing study questionnaires have been diagnosed with local recurrence and may be undergoing treatment for this.
EQ5D questionnaire and a demographic questionnaire
questionnaires
Distant disease
Women who have been treated for early breast cancer with breast conserving surgery and radiotherapy and at the time of completing study questionnaires have been diagnosed with distant disease and may be undergoing treatment for this.
EQ5D questionnaire and a demographic questionnaire
questionnaires
Mastectomy
Women who have been treated for early breast cancer with breast conserving surgery and radiotherapy and at the time of completing study questionnaires have undergone a mastectomy.
EQ5D questionnaire and a demographic questionnaire
questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EQ5D questionnaire and a demographic questionnaire
questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over 18 year of age
* Has had breast cancer, treated with both breast conserving surgery and radiotherapy.
* Is willing to complete an EQ5D and a demographic questionnaire.
Exclusion Criteria
* Has not already been approached to complete an OSTaRa questionnaire.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College, London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Great Western Hospitals NHS Foundation Trust
Swindon, Wiltshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18/0059
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.